GB2013691B - Immune gammaglobulin preparation for the treatment of rheumatoid arthritis - Google Patents
Immune gammaglobulin preparation for the treatment of rheumatoid arthritisInfo
- Publication number
- GB2013691B GB2013691B GB7903836A GB7903836A GB2013691B GB 2013691 B GB2013691 B GB 2013691B GB 7903836 A GB7903836 A GB 7903836A GB 7903836 A GB7903836 A GB 7903836A GB 2013691 B GB2013691 B GB 2013691B
- Authority
- GB
- United Kingdom
- Prior art keywords
- gammaglobulin
- immune
- preparation
- treatment
- rheumatoid arthritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0266—Klebsiella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0283—Shigella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87514078A | 1978-02-06 | 1978-02-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2013691A GB2013691A (en) | 1979-08-15 |
GB2013691B true GB2013691B (en) | 1982-08-18 |
Family
ID=25365266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB7903836A Expired GB2013691B (en) | 1978-02-06 | 1979-02-02 | Immune gammaglobulin preparation for the treatment of rheumatoid arthritis |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS54113425A (en) |
CH (1) | CH651210A5 (en) |
DE (1) | DE2904044C2 (en) |
DK (1) | DK158138C (en) |
FR (1) | FR2416015A1 (en) |
GB (1) | GB2013691B (en) |
HK (1) | HK30283A (en) |
IT (1) | IT1116524B (en) |
NL (1) | NL7900766A (en) |
SE (1) | SE448344B (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4732757A (en) * | 1978-02-06 | 1988-03-22 | Stolle Research And Development Corporation | Prevention and treatment of rheumatoid arthritis |
USRE33565E (en) * | 1978-02-06 | 1991-04-02 | Stolle Research And Development Corporation | Prevention and treatment of rheumatioid arthritis |
AU558931B2 (en) * | 1981-02-26 | 1987-02-12 | Unilever Plc | A process and apparatus for the recovery of immunoglobulins |
DE3172807D1 (en) * | 1981-04-28 | 1985-12-12 | Stolle Res & Dev | Method of obtaining an anti-inflammatory bovine milk |
JP2561234B2 (en) * | 1981-05-12 | 1996-12-04 | スト−ル・リサ−チ・アンド・デイベロップメント・コ−ポレ−ション | Anti-inflammatory agent |
JPS58154513A (en) * | 1982-03-09 | 1983-09-14 | Sendai Biseibutsu Kenkyusho | Preventive and remedying drug |
US4636384A (en) * | 1982-06-03 | 1987-01-13 | Stolle Research & Development Corporation | Method for treating disorders of the vascular and pulmonary systems |
EP0127712B1 (en) * | 1983-06-07 | 1989-01-11 | The Stolle Research And Development Corporation | Deodorant containing bacterial antibodies |
JPS6112629A (en) * | 1984-06-28 | 1986-01-21 | Lion Corp | Composition for oral cavity application |
ATE87215T1 (en) * | 1987-07-21 | 1993-04-15 | Stolle Res & Dev | METHOD OF OBTAINING IMMUNO-REGULATORY FACTORS USING MAMMALIAN IMMUNIZATION. |
JP2664906B2 (en) * | 1987-08-13 | 1997-10-22 | ストール・リサーチ・アンド・デイベロップメント・コーポレーション | Improved mammalian immunization |
EP1171161A1 (en) * | 1999-04-19 | 2002-01-16 | Richard Weisbart | Treatment of adult rheumatoid arthritis by oral administration of pooled human immunoglobulin and an antacid |
JP2004525077A (en) * | 2000-09-28 | 2004-08-19 | リサーチ コーポレイション テクノロジーズ,インコーポレイテッド | Treatment of immune-mediated diseases by oral administration of immunoglobulin G enriched plasma fraction |
CA2437099A1 (en) * | 2001-01-30 | 2002-10-10 | The Lauridsen Group, Incorporated | Methods and compositions for treatment of immune dysfunction disorders |
AU2002309486A1 (en) * | 2001-01-30 | 2002-10-15 | The Lauridsen Group, Incorporated | Methods and compositions for modulating the immune system of animals |
JP4960632B2 (en) * | 2006-01-10 | 2012-06-27 | 学校法人北里研究所 | Composition for treating and preventing herpes simplex virus infection comprising immune milk composition as active ingredient |
JP5361132B2 (en) * | 2006-03-10 | 2013-12-04 | 国立大学法人信州大学 | An oral immunomodulator containing immunoglobulin G, a method for producing the same, and a food or drink comprising the oral immunomodulator |
JP2008179572A (en) * | 2007-01-25 | 2008-08-07 | Shinshu Univ | IMMUNOGLOBULIN Fc FRAGMENT RECEPTOR PROTEIN AND/OR PRODUCTION INHIBITOR OF IMMUNOGLOBULIN Fc FRAGMENT RECEPTOR LIKE PROTEIN, AND USE OF THE SAME |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5136326B1 (en) * | 1965-10-24 | 1976-10-07 | ||
DE1617769A1 (en) * | 1967-06-10 | 1971-04-01 | Rehm Eberhard | Process for the production of milk containing specific antibodies and preparations made therefrom |
JPS5136326A (en) * | 1974-09-24 | 1976-03-27 | Komatsu Seiren Co | SEIKEIGORU FUBOORU |
JPS5837285B2 (en) * | 1975-05-29 | 1983-08-15 | カブシキガイシヤ ミドリジユウジ | It is very difficult to understand the situation. |
JPS521014A (en) * | 1975-06-17 | 1977-01-06 | Stolle Res & Dev | Pharmaceutically acceptable carrier containing milk immunoglobulin |
JPS5381613A (en) * | 1976-12-28 | 1978-07-19 | Green Cross Corp:The | Remedies for enteral infection diseases |
CH627079A5 (en) * | 1977-04-15 | 1981-12-31 | Nestle Sa | Process for preparing a protein concentrate containing immunological factors of milk origin |
-
1979
- 1979-01-30 SE SE7900798A patent/SE448344B/en not_active IP Right Cessation
- 1979-01-31 NL NL7900766A patent/NL7900766A/en not_active Application Discontinuation
- 1979-02-02 GB GB7903836A patent/GB2013691B/en not_active Expired
- 1979-02-02 DE DE2904044A patent/DE2904044C2/en not_active Expired
- 1979-02-02 FR FR7902807A patent/FR2416015A1/en active Granted
- 1979-02-05 JP JP1215279A patent/JPS54113425A/en active Granted
- 1979-02-05 IT IT47888/79A patent/IT1116524B/en active
- 1979-02-06 CH CH1168/79A patent/CH651210A5/en not_active IP Right Cessation
- 1979-02-06 DK DK049479A patent/DK158138C/en not_active IP Right Cessation
-
1983
- 1983-08-25 HK HK302/83A patent/HK30283A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE2904044A1 (en) | 1979-08-30 |
FR2416015B1 (en) | 1983-06-17 |
SE7900798L (en) | 1979-08-07 |
JPS54113425A (en) | 1979-09-05 |
IT7947888A0 (en) | 1979-02-05 |
DK158138B (en) | 1990-04-02 |
NL7900766A (en) | 1979-08-08 |
SE448344B (en) | 1987-02-16 |
DK158138C (en) | 1990-08-27 |
GB2013691A (en) | 1979-08-15 |
IT1116524B (en) | 1986-02-10 |
JPH0160455B2 (en) | 1989-12-22 |
HK30283A (en) | 1983-09-02 |
CH651210A5 (en) | 1985-09-13 |
DE2904044C2 (en) | 1986-02-06 |
DK49479A (en) | 1979-08-07 |
FR2416015A1 (en) | 1979-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2964427D1 (en) | Process for the preparation of furanyl-benzazoles | |
GB2013691B (en) | Immune gammaglobulin preparation for the treatment of rheumatoid arthritis | |
DE2966723D1 (en) | Process for the preparation of 6-amino-6-desoxy-l-sorbose | |
HRP970093B1 (en) | Process for the preparation of imidazolylvinylethers | |
DE2960539D1 (en) | Process for the preparation of 4-fluor-3-phenoxytoluene | |
ZA796467B (en) | Process for the preparation of hydrocarbons | |
IL57539A0 (en) | Process for the preparation of 0-methoallyl-oxyphenol | |
DE2964389D1 (en) | Process for the preparation of 2-imidazolines | |
DE2963068D1 (en) | Process for the preparation of benzothiazole-disulphide | |
ZA791977B (en) | Process for the preparation of 6-halo-pregnanes | |
DE2961140D1 (en) | Process for the preparation of azaspirodecanes | |
DE2961237D1 (en) | Process for the preparation of hydroxyalkyl-perfluoralkane-sulfonamides | |
GB2037808B (en) | Process for the preparation of hydrocarbons | |
DE2960278D1 (en) | Process for the preparation of 4-acyloxy-2-methylcrotonaldehydes | |
MY8500529A (en) | Process for the preparation of 1-n-acyl-amininoglycosides | |
ZA796547B (en) | Process for the preparation of hydrocarbons | |
DE2962108D1 (en) | Process for the preparation of 4-methyl-2-amino-benzothiazole | |
GB2015998B (en) | Process for the preparation of p-amino-diphenylamine | |
DE2960541D1 (en) | Process for the preparation of 3-phenoxybenzaldehydes | |
DE2961888D1 (en) | Process for the preparation of 6-hydroxypyrid-2-ones | |
DE2961447D1 (en) | Process for the preparation of p-nitroso-diphenylhydroxylamines | |
DE2964895D1 (en) | Process for the preparation of isopropylamino-2-pyrimidine | |
GB2088852B (en) | Process for the preparation of 9-oxobenzomorphans | |
DE2860555D1 (en) | Process for the preparation of 4-methyl-5-chloromethyl-imidazole | |
DE2961975D1 (en) | Process for the preparation of 5-diethylamino-2-pentanol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PE20 | Patent expired after termination of 20 years |
Effective date: 19990201 |